ARCHIVES

In Brief: Board Subcommittee Meetings On Comprehensive Centers Postponed; FDA Committee Uncharted

This article is from The Cancer Letter archive.

Vol. 04 No. 10 | March 10, 1978

Download PDF Visit The Full Archive

Related Articles

In Brief: Registration Deadlines Coming Up For 13th Cancer Congress; Breast Cancer Meeting Postponed To ‘83

May 28, 1982

NCAB Subcommittee drafting Report Bioassay-Human Risk Relationship

February 16, 1979

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

EU Gives Marketing Approval For HBV Sequencing Test

April 29, 2011

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010